Hasse Kromann is currently working in an Outsourcing and Contract Management function at Genmab A/S, a biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. Prior to working in Genmab Hasse acted as Director of MedChem ApS for 4½ years. MedChem, which was co-founded by Hasse in 2003, was a small Contract Research Organization, which focused on early drug development and synthesis of biologically active small molecules. Finally, Hasse has work as a chemist within small biotech companies in the Copenhagen area. Hasse holds a PhD in Medicinal Chemistry from the Royal Danish School of Pharmacy and a MBA from Copenhagen Business School.